Impact of intranasal insulin on insulin antibody affinity and isotypes in young children with HLA-conferred susceptibility to type 1 diabetes (Q35043241)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Impact of intranasal insulin on insulin antibody affinity and isotypes in young children with HLA-conferred susceptibility to type 1 diabetes	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

6 August 2017

Impact of intranasal insulin on insulin antibody affinity and isotypes in young children with HLA-conferred susceptibility to type 1 diabetes (English)

1 reference

Europe PubMed Central

6 August 2017

type-1 diabetes

1 reference

based on heuristic

inferred from title

6

object named as

Heikki Hyöty

0 references

8

object named as

Riitta Veijola

0 references

Kirsti Näntö-Salonen

4

object named as

Kirsti Näntö-Salonen

0 references

Taina Härkönen

2

object named as

Taina Härkönen

0 references

3

object named as

Heli Siljander

0 references

Samppa J. Ryhänen

object named as

Samppa J Ryhänen

1

0 references

object named as

Jorma Ilonen

7

0 references

object named as

Mikael Knip

10

0 references

author name string

Tuula Simell

5

1 reference

Europe PubMed Central

6 August 2017

Olli Simell

9

1 reference

Europe PubMed Central

6 August 2017

language of work or name

0 references

publication date

22 April 2011

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

34

1 reference

Europe PubMed Central

6 August 2017

6

1 reference

Europe PubMed Central

6 August 2017

1383-1388

1 reference

Europe PubMed Central

6 August 2017

copyright license

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

28 August 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114329

8 July 2018

Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114329

8 July 2018

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114329

8 July 2018

Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114329

8 July 2018

Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114329

8 July 2018

Role of insulin autoantibody affinity as a predictive marker for type 1 diabetes in young children with HLA-conferred disease susceptibility.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114329

25 October 2018

Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114329

25 October 2018

Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114329

25 October 2018

Effects of insulin in relatives of patients with type 1 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114329

25 October 2018

IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114329

25 October 2018

Insulin prophylaxis in individuals at high risk of type I diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3114329

25 October 2018

Immunological and metabolic effects of prophylactic insulin therapy in the NOD-scid/scid adoptive transfer model of IDDM

1 reference

https://pubmed.ncbi.nlm.nih.gov/21515841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel micro-assay for insulin autoantibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21515841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/21515841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In insulin-autoantibody-positive children from the general population, antibody affinity identifies those at high and low risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/21515841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21515841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population-based genetic screening for the estimation of Type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci

1 reference

https://pubmed.ncbi.nlm.nih.gov/21515841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21515841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin autoantibody isotypes during the prediabetic process in young children with increased genetic risk of type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21515841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triple-label hybridization assay for type-1 diabetes-related HLA alleles

1 reference

https://pubmed.ncbi.nlm.nih.gov/21515841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. The Childhood Diabetes in Finland (DiMe) Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21515841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2337/DC10-1449

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35043241&oldid=2087488224"